EIT Pathogena is on a mission to revolutionise infectious disease management by creating a sustainable, data-driven global system. With a focus on the growing threats of antimicrobial resistance (AMR) and emerging infectious diseases, we foster partnerships to develop transformative solutions. Our innovative model aims to combine cutting-edge technologies and artificial intelligence to enhance treatment precision and predict potential outbreaks.

Central to our vision is the creation of the world’s largest pathogen reference database, powered by global data-sharing networks. This collaborative approach enables early outbreak detection, improves health outcomes, and empowers healthcare providers worldwide. We are also advancing analysis pipelines for pathogens, including Mycobacterium tuberculosis and non-tuberculous mycobacteria (NTMs), accelerating progress in the accurate diagnosis and treatment of these diseases.

As the first scientific programme of the Ellison Institute of Technology at Oxford, we are leading the charge in transforming global health. By integrating genomic insights into routine healthcare, we strive to move beyond siloed efforts, aiming for a global impact that tackles infectious diseases at scale.